Tenax Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
TENX
CUSIP
88032L605
Type
Equity
Class
COM NEW
Num filings
129
Total reported value, excl. options
$442 M
Manager Report Date Value ($000) Shares Option Type